{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:14Z","timestamp":1772166314225,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute hepatic porphyria (AHP) constitutes a class of rare diseases caused by reduced function in enzymes of the heme-biosynthetic pathway. AHP includes acute intermittent porphyria (AIP), hereditary coproporphyria (HCP), variegate porphyria (VP) and the extremely rare \u03b4-aminolevulinic-dehydrase deficiency porphyria (ADP). This retrospective study describes characteristics of the Danish AHP patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Department of Endocrinology at Odense University Hospital serves as national AHP center. We performed a 5-year retrospective description of our AHP cohort using electronic patient journals. We included general symptoms, number of acute attacks, hospitalization rates, long-term sequelae and symptoms, and grouped patients according to creatinine-adjusted urinary baseline excretion (i.e., outside attacks) of the porphyrin precursor porphobilinogen (PBG) in normal-, moderate- and high-excretion and unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The cohort contained 129 AHP patients, hereof 100 AIP, 12 HCP and 17 VP. Median age was 46.3 (32.1\u201362.0) years, and 85 (65.9%) were female. During the 5-years, 38 (29.5%) patients experienced symptoms. Hereof, 20 patients were hospitalized with acute attacks or chronic symptoms and treated with human hemin (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914). Most frequently reported symptoms were abdominal pain, nausea, vomiting, and neurological disturbances. Symptoms were more common in patients with high PBG baseline excretion (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939) as compared to those with moderate (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931) or normal (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) PBG excretion (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Furthermore, females dominated the symptomatic group (68.4%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>As reported internationally, AHP is more commonly diagnosed and symptomatic in women, and AIP was the most frequent AHP subtype. Those with an elevated urinary baseline PBG secretion were more likely to report AHP-related symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03536-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:04:35Z","timestamp":1740740675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute hepatic porphyria in Denmark; a retrospective study"],"prefix":"10.1186","volume":"20","author":[{"given":"Magnus Emil Ulrich","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-0961","authenticated-orcid":false,"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"3536_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tgh-2020-01","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B. The acute hepatic porphyrias. Transl Gastroenterol Hepatol. 2021;6:24.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"3536_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ymgme.2019.04.008","volume":"128","author":"JD Phillips","year":"2019","unstructured":"Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164\u201377.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"3536_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1056\/NEJMra1608634","volume":"377","author":"DM Bissell","year":"2017","unstructured":"Bissell DM, Anderson KE, Bonkovsky HL. Porphyria. N Engl J Med. 2017;377(9):862\u201372.","journal-title":"N Engl J Med"},{"issue":"5","key":"3536_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","volume":"36","author":"G Elder","year":"2013","unstructured":"Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013;36(5):849\u201357.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"3536_CR5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/hep.30936","volume":"71","author":"L Gouya","year":"2020","unstructured":"Gouya L, Ventura P, Balwani M, Bissell DM, Rees DC, St\u00f6lzel U, et al. EXPLORE: A prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. Hepatology. 2020;71(5):1546\u201358.","journal-title":"Hepatology"},{"issue":"3","key":"3536_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","volume":"164","author":"B Wang","year":"2023","unstructured":"Wang B, Bonkovsky HL, Lim JK, Balwani M. AGA clinical practice update on diagnosis and management of acute hepatic porphyrias: expert review. Gastroenterology. 2023;164(3):484\u201391.","journal-title":"Gastroenterology"},{"key":"3536_CR7","volume-title":"Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease","author":"B Wang","year":"2020","unstructured":"Wang B, Bissell DM. The acute porphyrias. In: Juan MP, Roger NR, editors. Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease. 6th ed. Academic Press; 2020.","edition":"6"},{"key":"3536_CR8","unstructured":"Kothadia JP, LaFreniere K, Shah JM. Acute hepatic porphyria. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"issue":"12","key":"3536_CR9","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/00207454.2019.1655014","volume":"129","author":"Y Suh","year":"2019","unstructured":"Suh Y, Gandhi J, Seyam O, Jiang W, Joshi G, Smith NL, et al. Neurological and neuropsychiatric manifestations of porphyria. Int J Neurosci. 2019;129(12):1226\u201333.","journal-title":"Int J Neurosci"},{"issue":"2","key":"3536_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.amjms.2021.03.004","volume":"362","author":"KE Anderson","year":"2021","unstructured":"Anderson KE, Lobo R, Salazar D, Schloetter M, Spitzer G, White AL, et al. Biochemical diagnosis of acute hepatic porphyria: Updated expert recommendations for primary care physicians. Am J Med Sci. 2021;362(2):113\u201321.","journal-title":"Am J Med Sci"},{"issue":"8","key":"3536_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4045\/tidsskr.13.0649","volume":"134","author":"M Mykletun","year":"2014","unstructured":"Mykletun M, Aarsand AK, St\u00f8le E, Villanger JH, Toll\u00e5nes MC, Baravelli C, et al. Porphyrias in Norway. Tidsskr Nor Laegeforen. 2014;134(8):831\u20136.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"4","key":"3536_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","volume":"39","author":"Z Karim","year":"2015","unstructured":"Karim Z, Lyoumi S, Nicolas G, Deybach J-C, Gouya L, Puy H. Porphyrias: a 2015 update. Clin Res Hepatol Gastroenterol. 2015;39(4):412\u201325.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"Pt 3","key":"3536_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0004563212473278","volume":"50","author":"SD Whatley","year":"2013","unstructured":"Whatley SD, Badminton MN. Role of genetic testing in the management of patients with inherited porphyria and their families. Ann Clin Biochem. 2013;50(Pt 3):204\u201316.","journal-title":"Ann Clin Biochem"},{"issue":"9718","key":"3536_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach J-C. Porphyrias. The Lancet. 2010;375(9718):924\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(09)61925-5.","journal-title":"The Lancet"},{"issue":"6","key":"3536_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/joim.13463","volume":"291","author":"M Lissing","year":"2022","unstructured":"Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M, et al. Risk of primary liver cancer in acute hepatic porphyria patients: a matched cohort study of 1244 individuals. J Intern Med. 2022;291(6):824\u201336.","journal-title":"J Intern Med"},{"issue":"5\u20136","key":"3536_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0020-711X(80)90180-9","volume":"12","author":"TK With","year":"1980","unstructured":"With TK. The different types of porphyria in Denmark and the importance of family studies. Int J Biochem. 1980;12(5\u20136):887\u20139.","journal-title":"Int J Biochem"},{"key":"3536_CR17","unstructured":"Denmark S. Population projections https:\/\/www.dst.dk\/en\/Statistik\/emner\/borgere\/befolkning\/befolkningsfremskrivning2022 [Available from: https:\/\/www.dst.dk\/en\/Statistik\/emner\/borgere\/befolkning\/befolkningsfremskrivning."},{"issue":"13","key":"3536_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/BF01721260","volume":"59","author":"M Doss","year":"1981","unstructured":"Doss M, Verspohl F. The, \u201cglucose effect\u201d in acute hepatic porphyrias and in experimental porphyria. Klin Wochenschr. 1981;59(13):727\u201335.","journal-title":"Klin Wochenschr"},{"issue":"12","key":"3536_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL Bonkovsky","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, et al. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014;127(12):1233\u201341.","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"3536_CR20","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.33549\/physiolres.930000.55.S2.109","volume":"55","author":"S Thunell","year":"2006","unstructured":"Thunell S, Floderus Y, Henrichson A, Harper P. Porphyria in Sweden. Physiol Res. 2006;55(Suppl 2):S109\u201318.","journal-title":"Physiol Res"},{"key":"3536_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16012","author":"AK Aarsand","year":"2024","unstructured":"Aarsand AK, To-Figueras J, Whatley S, Sandberg S, Schmitt C. Practical recommendations for biochemical and genetic diagnosis of the porphyrias. Liver Int. 2024. https:\/\/doi.org\/10.1111\/liv.16012.","journal-title":"Liver Int"},{"issue":"4","key":"3536_CR22","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hep.29313","volume":"66","author":"M Balwani","year":"2017","unstructured":"Balwani M, Wang B, Anderson KE, Bloomer JR, Bissell DM, Bonkovsky HL, et al. Acute hepatic porphyrias: recommendations for evaluation and long-term management. Hepatology (Baltimore, MD). 2017;66(4):1314\u201322.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"11","key":"3536_CR23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1038\/s41436-019-0537-7","volume":"21","author":"B Chen","year":"2019","unstructured":"Chen B, Whatley S, Badminton M, Aarsand AK, Anderson KE, Bissell DM, et al. International porphyria molecular diagnostic collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias. Genet Med. 2019;21(11):2605\u201313.","journal-title":"Genet Med"},{"issue":"1","key":"3536_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/00016340903390729","volume":"89","author":"E Innala","year":"2010","unstructured":"Innala E, B\u00e4ckstr\u00f6m T, Bixo M, Andersson C. Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria. Acta Obstet Gynecol Scand. 2010;89(1):95\u2013100.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"3536_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2796.2003.01172.x","volume":"254","author":"C Andersson","year":"2003","unstructured":"Andersson C, Innala E, B\u00e4ckstr\u00f6m T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population\u2010based study in northern Sweden. J Int Med. 2003;254(2):176\u201383. https:\/\/doi.org\/10.1046\/j.1365-2796.2003.01172.x.","journal-title":"J Int Med"},{"issue":"1","key":"3536_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","volume":"84","author":"RJ Hift","year":"2005","unstructured":"Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine (Baltimore). 2005;84(1):48\u201360.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"3536_CR27","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.clinph.2011.07.036","volume":"122","author":"CS Lin","year":"2011","unstructured":"Lin CS, Lee MJ, Park SB, Kiernan MC. Purple pigments: the pathophysiology of acute porphyric neuropathy. Clin Neurophysiol. 2011;122(12):2336\u201344.","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"3536_CR28","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1590\/S0004-282X2011000700029","volume":"69","author":"AA Carvalho","year":"2011","unstructured":"Carvalho AA, Ar\u00e7ari DD. Acute intermittent porphyria after gastroplasty. Arq Neuropsiquiatr. 2011;69(6):992.","journal-title":"Arq Neuropsiquiatr"},{"issue":"11","key":"3536_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.amjmed.2012.01.028","volume":"125","author":"F Danion","year":"2012","unstructured":"Danion F, Guillot M, Castelain V, Puy H, Deybach JC, Schneider F. An uncommon option for surviving bariatric surgery: regaining weight! Am J Med. 2012;125(11):e1-2.","journal-title":"Am J Med"},{"issue":"26","key":"3536_CR30","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1056\/NEJMcpc0803190","volume":"358","author":"HL Bonkovsky","year":"2008","unstructured":"Bonkovsky HL, Siao P, Roig Z, Hedley-Whyte ET, Flotte TJ. Case 20\u20132008. N Engl J Med. 2008;358(26):2813\u201325.","journal-title":"N Engl J Med"},{"issue":"4","key":"3536_CR31","first-page":"319","volume":"248","author":"C Andersson","year":"2000","unstructured":"Andersson C, Wikberg A, Stegmayr B, Lithner F. Renal symptomatology in patients with acute intermittent porphyria. A Population-Based Stud J Intern Med. 2000;248(4):319\u201325.","journal-title":"A Population-Based Stud J Intern Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03536-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03536-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:04:38Z","timestamp":1740740678000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03536-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3536"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03536-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4848550\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was obtained from the hospital\u2019s legal department prior to start.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submit this manuscript to Orphanet J of Rare Diseases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}